Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway

Experimental Cell Research

Volumn 322, Issue 2, 2014, Pages 355-364

  Guezguez, Amel ^a   Paré, Fréderic ^a   Benoit, Yannick D ^a,b   Basora, Nuria ^a   Beaulieu, Jean François ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

BMP; Cell culture; Intestine; LGR5; Stem cell; WNT

Indexed keywords

BETA CATENIN; CYCLIN D2; GLYCOGEN SYNTHASE KINASE 3BETA; T CELL FACTOR PROTEIN; WNT PROTEIN; WNT3A PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CRYPT CELL; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; WNT SIGNALING PATHWAY;

BMP; CELL CULTURE; INTESTINE; LGR5; STEM CELL; WNT;

ADULT; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FETUS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HUMANS; INTESTINES; LUCIFERASES; REAL-TIME POLYMERASE CHAIN REACTION; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEM CELLS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84896049938     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.02.009     Document Type: Article

References (74)

1. Bjerknes M., Cheng H. Gastrointestinal stem cells. II. Intestinal stem cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G381-G387.
2. Scoville D.H., Sato T., He X.C., Li L. Current view: intestinal stem cells and signaling. Gastroenterology 2008, 134:849-864.
3. Babyatsky M.W., Podolsky D.K. Growth and development of the gastrointestinal tract. Textbook of Gastroenterology 1999, 547-584. J.B Lippincott, Philadelphia. T. Yamada (Ed.).
4. van der Flier L.G., Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 2009, 71:241-260.
5. Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol. Biol. 2008, 468:5-15.
6. Li L., Clevers H. Coexistence of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
7. Potten C.S., Gandara R., Mahida Y.R., Loeffler M., Wright N.A. The stem cells of small intestinal crypts: where are they?. Cell Prolif. 2009, 42:731-750.
8. Yen T.H., Wright N.A. The gastrointestinal tract stem cell niche. Stem Cell Rev. 2006, 2:203-212.
9. Marshman E., Booth C., Potten C.S. The intestinal epithelial stem cell. Bioessays 2002, 24:91-98.
10. Benoit Y.D., Lepage M.B., Khalfaoui T., Tremblay E., Basora N., Carrier J.C., Gudas L.J., Beaulieu J.F. Polycomb repressive complex 2 impedes intestinal cell terminal differentiation. J. Cell Sci. 2012, 125:3454-3463.
11. Seltana A., Guezguez A., Lepage M., Basora N., Beaulieu J.F. Src family kinase inhibitor PP2 accelerates differentiation in human intestinal epithelial cells. Biochem. Biophys. Res. Commun. 2013, 430:1195-1200.
12. Montgomery R.K., Mulberg A.E., Grand R.J. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology 1999, 116:702-731.
13. Pageot L.P., Perreault N., Basora N., Francoeur C., Magny P., Beaulieu J.F. Human cell models to study small intestinal functions: recapitulation of the crypt-villus axis. Microsc. Res. Tech. 2000, 49:394-406.
14. Crosnier C., Stamataki D., Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 2006, 7:349-359.
15. Medema J.P., Vermeulen L. Microenvironmental regulation of stem cells in intestinal homeostasis and cancer. Nature 2011, 474:318-326.
16. Vanuytsel T., Senger S., Fasano A., Shea-Donohue T. Major signaling pathways in intestinal stem cells. Biochim. Biophys. Acta 2013, 1830:2410-2426.
17. Gregorieff A., Clevers H. Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev. 2005, 19:877-890.
18. Sato T., van Es J.H., Snippert H.J., Stange D.E., Vries R.G., van den Born M., Barker N., Shroyer N.F., van de Wetering M., Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature 2011, 469:415-418.
19. Gregorieff A., Pinto D., Begthel H., Destree O., Kielman M., Clevers H. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 2005, 129:626-638.
20. Kazanskaya O., Glinka A., del Barco Barrantes I., Stannek P., Niehrs C., Wu W. R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. Dev. Cell 2004, 7:525-534.
21. He X.C., Zhang J., Tong W.G., Tawfik O., Ross J., Scoville D.H., Tian Q., Zeng X., He X., Wiedemann L.M., Mishina Y., Li L. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 2004, 36:1117-1121.
22. Haramis A.P., Begthel H., van den Born M., van Es J., Jonkheer S., Offerhaus G.J., Clevers H. De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine. Science 2004, 303:1684-1686.
23. Arndt S., Maegdefrau U., Dorn C., Schardt K., Hellerbrand C., Bosserhoff A.K. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 2010, 138:372-382.
24. Cheng H., Leblond C.P. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am. J. Anat. 1974, 141:537-561.
25. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
26. Takeda N., Jain R., LeBoeuf M.R., Wang Q., Lu M.M., Epstein J.A. Interconversion between intestinal stem cell populations in distinct niches. Science 2011, 334:1420-1424.
27. Tian H., Biehs B., Warming S., Leong K.G., Rangell L., Klein O.D., de Sauvage F.J. A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable. Nature 2011, 478:255-259.
28. Yan K.S., Chia L.A., Li X., Ootani A., Su J., Lee J.Y., Su N., Luo Y., Heilshorn S.C., Amieva M.R., Sangiorgi E., Capecchi M.R., Kuo C.J. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:466-471.
29. van der Flier L.G., Haegebarth A., Stange D.E., van de Wetering M., Clevers H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 2009, 137:15-17.
30. Zhu L., Gibson P., Currle D.S., Tong Y., Richardson R.J., Bayazitov I.T., Poppleton H., Zakharenko S., Ellison D.W., Gilbertson R.J. Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 2009, 457:603-607.
31. Snippert H.J., van Es J.H., van den Born M., Begthel H., Stange D.E., Barker N., Clevers H. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. Gastroenterology 2009, 136:2187-2194. (e2181).
32. Sakthianandeswaren A., Christie M., D'Andreti C., Tsui C., Jorissen R.N., Li S., Fleming N.I., Gibbs P., Lipton L., Malaterre J., Ramsay R.G., Phesse T.J., Ernst M., Jeffery R.E., Poulsom R., Leedham S.J., Segditsas S., Tomlinson I.P., Bernhard O.K., Simpson R.J., Walker F., Faux M.C., Church N., Catimel B., Flanagan D.J., Vincan E., Sieber O.M. PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res. 2011, 71:3709-3719.
33. Munoz J., Stange D.E., Schepers A.G., van de Wetering M., Koo B.K., Itzkovitz S., Volckmann R., Kung K.S., Koster J., Radulescu S., Myant K., Versteeg R., Sansom O.J., van Es J.H., Barker N., van Oudenaarden A., Mohammed S., Heck A.J., Clevers H. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4' cell markers. EMBO J. 2012, 31:3079-3091.
34. Perreault N., Beaulieu J.F. Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp. Cell Res. 1996, 224:354-364.
35. Desloges N., Basora N., Perreault N., Bouatrouss Y., Sheppard D., Beaulieu J.F. Regulated expression of the integrin alpha9beta1 in the epithelium of the developing human gut and in intestinal cell lines: relation with cell proliferation. J. Cell. Biochem. 1998, 71:536-545.
36. Basora N., Herring-Gillam F.E., Boudreau F., Perreault N., Pageot L.P., Simoneau M., Bouatrouss Y., Beaulieu J.F. Expression of functionally distinct variants of the beta(4)A integrin subunit in relation to the differentiation state in human intestinal cells. J. Biol. Chem. 1999, 274:29819-29825.
37. Benoit Y.D., Lussier C., Ducharme P.A., Sivret S., Schnapp L.M., Basora N., Beaulieu J.F. Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism. Biol. Cell 2009, 101:695-708.
38. Benoit Y.D., Pare F., Francoeur C., Jean D., Tremblay E., Boudreau F., Escaffit F., Beaulieu J.F. Cooperation between HNF-1alpha, Cdx2, and GATA-4 in initiating an enterocytic differentiation program in a normal human intestinal epithelial progenitor cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G504-G517.
39. Quaroni A., Beaulieu J.F. Cell dynamics and differentiation of conditionally immortalized human intestinal epithelial cells. Gastroenterology 1997, 113:1198-1213.
40. Beaulieu J.F., Menard D. Isolation, characterization, and culture of normal human intestinal crypt and villus cells. Methods Mol. Biol. 2012, 806:157-173.
41. Gagne D., Groulx J.F., Benoit Y.D., Basora N., Herring E., Vachon P.H., Beaulieu J.F. Integrin-linked kinase regulates migration and proliferation of human intestinal cells under a fibronectin-dependent mechanism. J. Cell. Physiol. 2010, 222:387-400.
42. Begue B., Wajant H., Bambou J.C., Dubuquoy L., Siegmund D., Beaulieu J.F., Canioni D., Berrebi D., Brousse N., Desreumaux P., Schmitz J., Lentze M.J., Goulet O., Cerf-Bensussan N., Ruemmele F.M. Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology 2006, 130:1962-1974.
43. Francoeur C., Escaffit F., Vachon P.H., Beaulieu J.F. Proinflammatory cytokines TNF-alpha and IFN-gamma alter laminin expression under an apoptosis-independent mechanism in human intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G592-G598.
44. Harnois C., Demers M.J., Bouchard V., Vallee K., Gagne D., Fujita N., Tsuruo T., Vezina A., Beaulieu J.F., Cote A., Vachon P.H. Human intestinal epithelial crypt cell survival and death: complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1, MEK/Erk, and p38 signaling pathways. J. Cell. Physiol. 2004, 198:209-222.
45. Simoneau A., Herring-Gillam F.E., Vachon P.H., Perreault N., Basora N., Bouatrouss Y., Pageot L.P., Zhou J., Beaulieu J.F. Identification, distribution, and tissular origin of the alpha5(IV) and alpha6(IV) collagen chains in the developing human intestine. Dev. Dyn. 1998, 212:437-447.
46. Levy E., Beaulieu J.F., Delvin E., Seidman E., Yotov W., Basque J.R., Menard D. Human crypt intestinal epithelial cells are capable of lipid production, apolipoprotein synthesis, and lipoprotein assembly. J. Lipid Res. 2000, 41:12-22.
47. Benoit Y.D., Larrivee J.F., Groulx J.F., Stankova J., Vachon P.H., Beaulieu J.F. Integrin alpha8beta1 confers anoikis susceptibility to human intestinal epithelial crypt cells. Biochem. Biophys. Res. Commun. 2010, 399:434-439.
48. Basora N., Desloges N., Chang Q., Bouatrouss Y., Gosselin J., Poisson J., Sheppard D., Beaulieu J.F. Expression of the alpha9beta1 integrin in human colonic epithelial cells: resurgence of the fetal phenotype in a subset of colon cancers and adenocarcinoma cell lines. Int. J. Cancer 1998, 75:738-743.
49. Dydensborg A.B., Herring E., Auclair J., Tremblay E., Beaulieu J.F. Normalizing genes for quantitative RT-PCR in differentiating human intestinal epithelial cells and adenocarcinomas of the colon. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 290:G1067-G1074.
50. Ni H., Dydensborg A.B., Herring F.E., Basora N., Gagne D., Vachon P.H., Beaulieu J.F. Upregulation of a functional form of the beta4 integrin subunit in colorectal cancers correlates with c-Myc expression. Oncogene 2005, 24:6820-6829.
51. Escaffit F., Boudreau F., Beaulieu J.F. Differential expression of claudin-2 along the human intestine: Implication of GATA-4 in the maintenance of claudin-2 in differentiating cells. J. Cell. Physiol. 2005, 203:15-26.
52. Ilyas M., Tomlinson I.P., Rowan A., Pignatelli M., Bodmer W.F. Beta-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10330-10334.
53. Niehrs C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 2012, 13:767-779.
54. Birchmeier W. Stem cells: orphan receptors find a home. Nature 2011, 476:287-288.
55. Schuijers J., Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J. 2012, 31:2685-2696.
56. Braeuning A., Buchmann A. The glycogen synthase kinase inhibitor 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763) is a partial agonist of the aryl hydrocarbon receptor. Drug Metab. Dispos. 2009, 37:1576-1580.
57. Inoda S., Hirohashi Y., Torigoe T., Morita R., Takahashi A., Asanuma H., Nakatsugawa M., Nishizawa S., Tamura Y., Tsuruma T., Terui T., Kondo T., Ishitani K., Hasegawa T., Hirata K., Sato N. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells. Am. J. Pathol. 2011, 178:1805-1813.
58. Benoit Y.D., Witherspoon M.S., Laursen K.B., Guezguez A., Beausejour M., Beaulieu J.F., Lipkin S.M., Gudas L.J. Pharmacological inhibition of polycomb repressive complex-2 activity induces apoptosis in human colon cancer stem cells. Exp. Cell Res. 2013.
59. Haegebarth A., Clevers H. Wnt signaling, lgr5, and stem cells in the intestine and skin. Am. J. Pathol. 2009, 174:715-721.
60. Grover P.K., Hardingham J.E., Cummins A.G. Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev. 2010, 29:761-775.
61. Inomata H., Haraguchi T., Sasai Y. Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation. Cell 2008, 134:854-865.
62. Rainger J., van Beusekom E., Ramsay J.K., McKie L., Al-Gazali L., Pallotta R., Saponari A., Branney P., Fisher M., Morrison H., Bicknell L., Gautier P., Perry P., Sokhi K., Sexton D., Bardakjian T.M., Schneider A.S., Elcioglu N., Ozkinay F., Koenig R., Megarbane A., Semerci C.N., Khan A., Zafar S., Hennekam R., Sousa S.B., Ramos L., Garavelli L., Furga A.S., Wischmeijer A., Jackson I.J., Gillessen-Kaesbach G., Brunner H.G., Wieczorek D., van Bokhoven H., Fitzpatrick D.R. Loss of the BMP antagonist, SMOC-1, causes Ophthalmo-acromelic (Waardenburg Anophthalmia) syndrome in humans and mice. PLoS Genet. 2011, 7:e1002114.
63. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
64. Barker N., Ridgway R.A., van Es J.H., van de Wetering M., Begthel H., van den Born M., Danenberg E., Clarke A.R., Sansom O.J., Clevers H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-611.
65. Leedham S.J., Brittan M., McDonald S.A., Wright N.A. Intestinal stem cells. J. Cell. Mol. Med. 2005, 9:11-24.
66. Raymond K., Deugnier M.A., Faraldo M.M., Glukhova M.A. Adhesion within the stem cell niches. Curr. Opin. Cell Biol. 2009, 21:623-629.
67. Couture L.A. Scalable pluripotent stem cell culture. Nat. Biotechnol. 2010, 28:562-563.
68. Clatworthy J.P., Subramanian V. Stem cells and the regulation of proliferation, differentiation and patterning in the intestinal epithelium: emerging insights from gene expression patterns, transgenic and gene ablation studies. Mech. Dev. 2001, 101:3-9.
69. McDonald S.A., Preston S.L., Lovell M.J., Wright N.A., Jankowski J.A. Mechanisms of disease: from stem cells to colorectal cancer. Nat. Clin. Pract. Gastroenterol. Hepatol. 2006, 3:267-274.
70. Sato T., Vries R.G., Snippert H.J., van de Wetering M., Barker N., Stange D.E., van Es J.H., Abo A., Kujala P., Peters P.J., Clevers H. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459:262-265.
71. Spence J.R., Mayhew C.N., Rankin S.A., Kuhar M.F., Vallance J.E., Tolle K., Hoskins E.E., Kalinichenko V.V., Wells S.I., Zorn A.M., Shroyer N.F., Wells J.M. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 2010.
72. Samuel S., Walsh R., Webb J., Robins A., Potten C., Mahida Y.R. Characterization of putative stem cells in isolated human colonic crypt epithelial cells and their interactions with myofibroblasts. Am. J. Physiol.: Cell Physiol. 2009, 296:C296-C305.
73. Gulati A.S., Ochsner S.A., Henning S.J. Molecular properties of side population-sorted cells from mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G286-G294.
74. von Furstenberg R.J., Gulati A.S., Baxi A., Doherty J.M., Stappenbeck T.S., Gracz A.D., Magness S.T., Henning S.J. Sorting mouse jejunal epithelial cells with CD24 yields a population with characteristics of intestinal stem cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2010.